Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -205.54%-102.23M | ---- | -389.04%-33.46M | ---- | 129.52%11.58M | ---- | -362.99%-39.22M | ---- | 201.85%14.91M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 77.34%-87K | ---- | -284.00%-384K | ---- | 64.91%-100K | ---- | 56.36%-285K | ---- | 52.30%-653K |
| Dividend (income)- adjustment | ---- | ---- | ---- | ---86K | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provisions: | ---- | -80.96%2.62M | ---- | 1,435.98%13.75M | ---- | --895K | ---- | ---- | ---- | -99.09%7K |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | 1,828.24%13.25M | ---- | --687K | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | 423.40%2.62M | ---- | 140.38%500K | ---- | --208K | ---- | ---- | ---- | -99.09%7K |
| Revaluation surplus: | ---- | ---- | ---- | -98.30%236K | ---- | 352.49%13.92M | ---- | --3.08M | ---- | ---- |
| -Other fair value changes | ---- | ---- | ---- | -98.30%236K | ---- | 352.49%13.92M | ---- | --3.08M | ---- | ---- |
| Asset sale loss (gain): | ---- | 21,600.00%1.51M | ---- | 97.07%-7K | ---- | -3,883.33%-239K | ---- | ---6K | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | --1.65M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -1,957.14%-144K | ---- | 97.07%-7K | ---- | -3,883.33%-239K | ---- | ---6K | ---- | ---- |
| Depreciation and amortization: | ---- | -66.00%2.41M | ---- | -31.65%7.1M | ---- | -20.54%10.38M | ---- | -19.60%13.07M | ---- | 93.68%16.25M |
| -Depreciation | ---- | -69.91%1.87M | ---- | -28.38%6.2M | ---- | -18.60%8.66M | ---- | -21.71%10.64M | ---- | 98.51%13.59M |
| Financial expense | ---- | -63.30%40K | ---- | -9.92%109K | ---- | -25.77%121K | ---- | -34.27%163K | ---- | -77.54%248K |
| Special items | ---- | -101.15%-4K | ---- | 85.56%347K | ---- | -19.74%187K | ---- | 539.62%233K | ---- | -114.56%-53K |
| Operating profit before the change of operating capital | ---- | -672.14%-95.75M | ---- | -133.74%-12.4M | ---- | 259.99%36.75M | ---- | -174.78%-22.97M | ---- | 670.51%30.72M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | 355.64%18M | ---- | 18.79%-7.04M | ---- | -320.42%-8.67M | ---- | 141.80%3.93M | ---- | -139.35%-9.41M |
| Accounts payable increase (decrease) | ---- | 9.13%-20.21M | ---- | -222.51%-22.24M | ---- | 129.94%18.15M | ---- | -495.16%-60.63M | ---- | 444.61%15.34M |
| prepayments (increase)decrease | ---- | -2,364.49%-29.01M | ---- | -133.72%-1.18M | ---- | -26.29%3.49M | ---- | 160.07%4.74M | ---- | -241.58%-7.88M |
| Special items for working capital changes | ---- | -46.74%31.58M | ---- | 339.35%59.29M | ---- | -135.62%-24.77M | ---- | 284.94%69.54M | ---- | -3,023.26%-37.6M |
| Cash from business operations | ---- | -680.49%-95.39M | ---- | -34.14%16.43M | ---- | 563.67%24.95M | ---- | 39.12%-5.38M | ---- | -147.93%-8.84M |
| Other taxs | ---- | 66.67%-494K | ---- | -609.28%-1.48M | ---- | 327.94%291K | ---- | 194.44%68K | ---- | 97.36%-72K |
| Dividend received - operating | ---- | ---- | ---- | --86K | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest received - operating | ---- | -77.34%87K | ---- | 284.00%384K | ---- | -64.91%100K | ---- | -56.36%285K | ---- | -52.30%653K |
| Special items of business | 121.89%15.97M | ---- | -1,154.47%-72.98M | ---- | -48.80%6.92M | ---- | 547.17%13.52M | ---- | -126.49%-3.02M | ---- |
| Net cash from operations | 121.89%15.97M | -721.23%-95.79M | -1,154.47%-72.98M | -39.15%15.42M | -48.80%6.92M | 604.00%25.34M | 547.17%13.52M | 39.11%-5.03M | -126.49%-3.02M | -148.35%-8.26M |
| Cash flow from investment activities | ||||||||||
| Loan receivable (increase) decrease | ---- | 200.00%390K | ---- | -414.52%-390K | ---- | 131.71%124K | ---- | -1,855.00%-391K | ---- | ---20K |
| Sale of fixed assets | ---- | 83,885.71%5.88M | ---- | -97.52%7K | ---- | 3,928.57%282K | ---- | --7K | ---- | ---- |
| Purchase of fixed assets | ---- | 84.41%-267K | ---- | 75.40%-1.71M | 82.65%-928K | -148.29%-6.96M | -678.46%-5.35M | 84.83%-2.8M | 93.01%-687K | -0.72%-18.48M |
| Sale of subsidiaries | ---- | ---3.23M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---1.53M | ---- | ---- | ---- | --2.69M | --2.69M | ---- |
| Recovery of cash from investments | ---- | ---- | ---- | -26.67%32.15M | -53.41%14.72M | 190.02%43.84M | --31.59M | --15.12M | ---- | ---- |
| Cash on investment | ---- | ---- | ---- | 77.77%-9.99M | 69.83%-9.44M | 15.85%-44.94M | ---31.28M | -1,235.15%-53.41M | ---- | ---4M |
| Other items in the investment business | 677.00%1.73M | ---- | 23.08%-300K | ---- | ---390K | ---- | ---- | ---- | -66.67%-15K | ---- |
| Net cash from investment operations | 677.00%1.73M | -85.03%2.78M | -107.57%-300K | 341.95%18.53M | 178.61%3.96M | 80.25%-7.66M | -353.52%-5.04M | -72.40%-38.79M | 120.21%1.99M | -23.01%-22.5M |
| Net cash before financing | 124.16%17.71M | -373.98%-93.02M | -773.34%-73.28M | 92.01%33.95M | 28.37%10.88M | 140.36%17.68M | 919.13%8.48M | -42.46%-43.82M | -165.55%-1.04M | -2,439.72%-30.76M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | -60.79%5.15M | ---- | 146.62%13.14M | ---- | --5.33M | ---- | ---- | ---- | ---- |
| Refund | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 68.68%-10M |
| Interest paid - financing | ---- | 63.30%-40K | ---- | 9.92%-109K | 31.25%-55K | 25.77%-121K | -25.00%-80K | 34.27%-163K | 55.86%-64K | 77.54%-248K |
| Other items of the financing business | ---- | ---- | ---458K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | ---- | -62.56%4.55M | -4.09%-458K | 241.11%12.16M | 64.63%-440K | 243.65%3.56M | -4.98%-1.24M | 80.82%-2.48M | 14.50%-1.19M | -115.03%-12.93M |
| Effect of rate | ---- | ---- | ---- | ---188K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net Cash | 124.01%17.71M | -291.87%-88.47M | -806.10%-73.74M | 117.02%46.11M | 44.36%10.44M | 145.89%21.25M | 425.86%7.23M | -5.97%-46.3M | -1,250.26%-2.22M | -151.50%-43.69M |
| Begining period cash | -90.14%9.67M | 87.94%98.14M | 87.94%98.14M | 68.60%52.22M | 68.60%52.22M | -59.92%30.97M | -59.92%30.97M | -36.12%77.27M | -36.12%77.27M | 234.83%120.96M |
| Cash at the end | 12.20%27.38M | -90.14%9.67M | -61.06%24.4M | 87.94%98.14M | 64.01%62.66M | 68.60%52.22M | -49.09%38.21M | -59.92%30.97M | -38.05%75.05M | -36.12%77.27M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | National Health Accounting Firm Limited | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.